Atlas Trials

Assessment of Rituximab's Immunomodulatory Synovial Effects (The ARISE Study)

Clinical trial NCT00147966 · COMPLETED

Trial details

NCT number
NCT00147966
Sponsor
University of California, San Diego
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Rheumatoid Arthritis
Start date
2008-06-01
Primary completion
2009-12-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.